{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:13:37Z","timestamp":1768454017052,"version":"3.49.0"},"reference-count":11,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.25122\/jml-2025-0146","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:05:33Z","timestamp":1763388333000},"page":"863-868","source":"Crossref","is-referenced-by-count":1,"title":["Dysregulation of the endocannabinoid system \u2013 a key factor in the progression of multiple sclerosis?"],"prefix":"10.25122","volume":"18","author":[{"given":"Andreea-Cristina","family":"Paraschiv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Neurology and Pediatric Neurology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"V\u0103c\u0103ra\u0219","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Neurology and Pediatric Neurology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Marge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Pelican Medical Center Oradea, Faculty of Medicine, Oradea, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitalie","family":"V\u0103c\u0103ra\u0219","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Neurology and Pediatric Neurology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","reference":[{"issue":"23","key":"ref1","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.2174\/138161208785740036","article-title":"The endocannabinoid system and multiple sclerosis","volume":"14","author":"Baker D, Pryce G","year":"2008","unstructured":"1. Baker D, Pryce G, The endocannabinoid system and multiple sclerosis, Curr Pharm Des, 2008;14(23):2326-36","journal-title":"Curr Pharm Des"},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ana.25808","article-title":"Identifying Progression in Multiple Sclerosis: New Perspectives","volume":"88","author":"Filippi M, Preziosa P, Langdon D, Lassmann H, Paul F, Rovira \u00c0, Schoonheim MM, Solari A, Stankoff B, Rocca MA","year":"2020","unstructured":"2. Filippi M, Preziosa P, Langdon D, Lassmann H, Paul F, Rovira \u00c0, Schoonheim MM, Solari A, Stankoff B, Rocca MA, Identifying Progression in Multiple Sclerosis: New Perspectives, Ann Neurol, 2020;88(3):438-452","journal-title":"Ann Neurol"},{"issue":"23","key":"ref3","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.2174\/138161208785740090","article-title":"CNS immune surveillance and neuroinflammation: endocannabinoids keep control","volume":"14","author":"Wolf SA, Tauber S, Ullrich O","year":"2008","unstructured":"3. Wolf SA, Tauber S, Ullrich O, CNS immune surveillance and neuroinflammation: endocannabinoids keep control, Curr Pharm Des, 2008;14(23):2266-78","journal-title":"Curr Pharm Des"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino L, Bisogno T, Di Marzo V","year":"2020","unstructured":"4. Cristino L, Bisogno T, Di Marzo V, Cannabinoids and the expanded endocannabinoid system in neurological disorders, Nat Rev Neurol, 2020;16(1):9-29","journal-title":"Nat Rev Neurol"},{"issue":"1-2","key":"ref5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jns.2009.07.021","article-title":"Plasma endocannabinoid levels in multiple sclerosis","volume":"287","author":"Jean-Gilles L, Feng S, Tench CR, Chapman V, Kendall DA, Barrett DA","year":"2009","unstructured":"5. Jean-Gilles L, Feng S, Tench CR, Chapman V, Kendall DA, Barrett DA, Plasma endocannabinoid levels in multiple sclerosis, J Neurol Sci, 2009;287(1-2):212-5","journal-title":"J Neurol Sci"},{"issue":"Pt 10","key":"ref6","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1093\/brain\/awm160","article-title":"The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis","volume":"130","author":"Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F","year":"2007","unstructured":"6. Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F, The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis, Brain, 2007;130(Pt 10):2543-53","journal-title":"Brain"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nbd.2005.03.002","article-title":"Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and\/or vanilloid receptors in a rat model of multiple sclerosis","volume":"20","author":"Cabranes A, Venderova K, de Lago E, Fezza F, S\u00e1nchez A, Mestre L","year":"2005","unstructured":"7. Cabranes A, Venderova K, de Lago E, Fezza F, S\u00e1nchez A, Mestre L, Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and\/or vanilloid receptors in a rat model of multiple sclerosis, Neurobiol Dis, 2005;20(2):207-17","journal-title":"Neurobiol Dis"},{"issue":"11","key":"ref8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/jnnp.2007.139071","article-title":"Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis","volume":"79","author":"Di Filippo M, Pini LA, Pelliccioli GP, Calabresi P, Sarchielli P","year":"2008","unstructured":"8. Di Filippo M, Pini LA, Pelliccioli GP, Calabresi P, Sarchielli P, Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis, J Neurol Neurosurg Psychiatry, 2008;79(11):1224-9","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"578087","DOI":"10.1016\/j.jneuroim.2023.578087","article-title":"The role of multiple sclerosis therapies on the dynamic of human gut microbiota","volume":"378","author":"Vacaras V, Muresanu DF, Buzoianu AD, Nistor C, Vesa SC, Paraschiv AC","year":"2023","unstructured":"9. Vacaras V, Muresanu DF, Buzoianu AD, Nistor C, Vesa SC, Paraschiv AC, The role of multiple sclerosis therapies on the dynamic of human gut microbiota, J Neuroimmunol, 2023;378578087","journal-title":"J Neuroimmunol"},{"issue":"4","key":"ref10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/1871527313666140618110049","article-title":"Effect of glatiramer acetate on peripheral blood brain-derived neurotrophic factor and phosphorylated TrkB levels in relapsing-remitting multiple sclerosis","volume":"13","author":"Vacaras V, Major ZZ, Muresanu DF, Krausz TL, Marginean I, Buzoianu DA","year":"2014","unstructured":"10. Vacaras V, Major ZZ, Muresanu DF, Krausz TL, Marginean I, Buzoianu DA, Effect of glatiramer acetate on peripheral blood brain-derived neurotrophic factor and phosphorylated TrkB levels in relapsing-remitting multiple sclerosis, CNS Neurol Disord Drug Targets, 2014;13(4):647-51","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"6","key":"ref11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.pjnns.2018.09.003","article-title":"Psychiatric comorbidity in multiple sclerosis","volume":"52","author":"Panda SP, Das RC, Srivastava K, Ratnam A, Sharma N","year":"2018","unstructured":"11. Panda SP, Das RC, Srivastava K, Ratnam A, Sharma N, Psychiatric comorbidity in multiple sclerosis, Neurol Neurochir Pol, 2018;52(6):704-709","journal-title":"Neurol Neurochir Pol"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-9-2025\/original-article-issue-9-2025\/dysregulation-of-the-endocannabinoid-system-a-key-factor-in-the-progression-of-multiple-sclerosis\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:05:46Z","timestamp":1763388346000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2025\/issue-9-2025\/original-article-issue-9-2025\/dysregulation-of-the-endocannabinoid-system-a-key-factor-in-the-progression-of-multiple-sclerosis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["JMedLife-18-863"],"URL":"https:\/\/doi.org\/10.25122\/jml-2025-0146","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}